Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CVS Caremark
Payers
AMA flags rising PBM concentration
Analysts note that the concentration of PBM markets increased from 82% in 2022 to 94% in 2024.
Cailey Gleeson
Sep 29, 2026 4:00pm
Fierce Pharma
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
May 28, 2026 11:20am
Hospitals allege CVS Health subsidiaries pocketed 340B savings
May 21, 2026 4:30pm
CVS to expand biosimilar formulary adoptions
May 5, 2026 11:15am
Jefferson Health sues drugmakers, PBMs over insulin prices
Jan 8, 2026 3:00pm
Fierce Pharma
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
